| Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial L Zhang, Y Huang, S Hong, Y Yang, G Yu, J Jia, P Peng, X Wu, Q Lin, X Xi, ... The Lancet 388 (10054), 1883-1892, 2016 | 498 | 2016 |
| LRRC25 inhibits type I IFN signaling by targeting ISG15‐associated RIG‐I for autophagic degradation Y Du, T Duan, Y Feng, Q Liu, M Lin, J Cui, RF Wang The EMBO journal 37 (3), 351-366, 2018 | 137 | 2018 |
| Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor‐2 L Lai, J Liu, D Zhai, Q Lin, L He, Y Dong, J Zhang, B Lu, Y Chen, Z Yi, ... British journal of pharmacology 165 (4b), 1084-1096, 2012 | 95 | 2012 |
| circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis C Hu, R Xia, X Zhang, T Li, Y Ye, G Li, R He, Z Li, Q Lin, S Zheng, R Chen Molecular cancer 21 (1), 24, 2022 | 76 | 2022 |
| An IonStar experimental strategy for MS1 ion current-based quantification using ultrahigh-field orbitrap: reproducible, in-depth, and accurate protein measurement in large cohorts X Shen, S Shen, J Li, Q Hu, L Nie, C Tu, X Wang, B Orsburn, J Wang, J Qu Journal of proteome research 16 (7), 2445-2456, 2017 | 76 | 2017 |
| Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β … C Zheng, Y Fang, W Tong, G Li, H Wu, W Zhou, Q Lin, F Yang, Z Yang, ... Journal of medicinal chemistry 57 (3), 600-612, 2014 | 72 | 2014 |
| Targeting pyruvate carboxylase by a small molecule suppresses breast cancer progression Q Lin, Y He, X Wang, Y Zhang, M Hu, W Guo, Y He, T Zhang, L Lai, Z Sun, ... Advanced Science 7 (9), 1903483, 2020 | 47 | 2020 |
| PKA turnover by the REGγ-proteasome modulates FoxO1 cellular activity and VEGF-induced angiogenesis S Liu, L Lai, Q Zuo, F Dai, L Wu, Y Wang, Q Zhou, J Liu, J Liu, L Li, Q Lin, ... Journal of molecular and cellular cardiology 72, 28-38, 2014 | 41 | 2014 |
| Knockdown lncRNA DLEU1 inhibits gliomas progression and promotes temozolomide chemosensitivity by regulating autophagy QL Lv, LC Wang, DC Li, QX Lin, XL Shen, HY Liu, M Li, YL Ji, CZ Qin, ... Frontiers in Pharmacology 11, 560543, 2020 | 33 | 2020 |
| Design and optimization of hybrid of 2, 4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents W Zhou, A Huang, Y Zhang, Q Lin, W Guo, Z You, Z Yi, M Liu, Y Chen European Journal of Medicinal Chemistry 96, 269-280, 2015 | 26 | 2015 |
| Polydatin suppresses ultraviolet B‐induced cyclooxygenase‐2 expression in vitro and in vivo via reduced production of reactive oxygen species YD He, YT Liu, QX Lin, J Zhu, Y Zhang, LY Wang, XL Ren, XY Ye British Journal of Dermatology 167 (4), 941-944, 2012 | 23 | 2012 |
| LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia X Wang, Q Lin, F Lv, N Liu, Y Xu, M Liu, Y Chen, Z Yi Leukemia 30 (7), 1465-1474, 2016 | 22 | 2016 |
| Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells DZ Xiao, B Dai, J Chen, Q Luo, XY Liu, QX Lin, XH Li, W Huang, XY Yu Cell Proliferation 44 (6), 582-590, 2011 | 21 | 2011 |
| Comparative proteomic analysis identifies key metabolic regulators of gemcitabine resistance in pancreatic cancer Q Lin, S Shen, Z Qian, SS Rasam, A Serratore, WJ Jusko, ES Kandel, ... Molecular & Cellular Proteomics 21 (10), 2022 | 9 | 2022 |
| Synergistic pharmacodynamic effects of gemcitabine and fibroblast growth factor receptor inhibitors on pancreatic cancer cell cycle kinetics and proliferation Q Lin, Z Qian, WJ Jusko, DE Mager, WW Ma, RM Straubinger Journal of Pharmacology and Experimental Therapeutics 377 (3), 370-384, 2021 | 7 | 2021 |
| The Fgl2 interaction with Tyrobp promotes the proliferation of cutaneous squamous cell carcinoma by regulating ERK-dependent autophagy M Zeng, Q Li, J Chen, W Huang, J Liu, C Wang, M Huang, H Li, S Zhou, ... International Journal of Medical Sciences 19 (1), 195, 2022 | 6 | 2022 |
| Highly reproducible quantitative proteomics analysis of pancreatic cancer cells reveals proteome-level effects of a novel combination drug therapy that induces cancer cell … S Rasam, Q Lin, S Shen, RM Straubinger, J Qu Journal of Proteome Research 22 (12), 3780-3792, 2023 | 4 | 2023 |
| FGFR1 expression correlates inversely with the efficacy of single-agent FGFR-specific inhibitors in pancreatic cancer Q Lin, A Serratore, J Perri, TR Chaudhuri, J Qu, WW Ma, RM Straubinger Br. J. Pharmacol 10, 2023 | 3 | 2023 |
| Dual-hit strategy for therapeutic targeting of pancreatic cancer in patient-derived xenograft tumors T Roy Chaudhuri, Q Lin, EK Stachowiak, SR Rosario, JA Spernyak, ... Clinical Cancer Research 30 (7), 1367-1381, 2024 | 2 | 2024 |
| Fibroblast growth factor receptor 1 inhibition suppresses pancreatic cancer chemoresistance and chemotherapy-driven aggressiveness Q Lin, A Serratore, J Niu, S Shen, TR Chaudhuri, WW Ma, J Qu, ... Drug Resistance Updates 73, 101064, 2024 | 1 | 2024 |
